$1.84
-0.095-4.91%
Last update: Nov 5, 7:18 PM
Processa Pharmaceuticals Inc (PCSA) Stock Price, Quote, News & History
PCSANASDAQ
Processa Pharmaceuticals' stock jumps after Phase 2 data show higher capecitabine exposure without added toxicity in metastatic breast cancer patients.
You can purchase shares of Processa Pharma (NASDAQ:PCSA) through any online brokerage.
Other companies in Processa Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Processa Pharma has a consensus price target of $62.50.
The stock price for Processa Pharma (NASDAQ: PCSA) is $1.79 last updated November 5, 2026 at 7:18 PM EST.
There are no upcoming dividends for Processa Pharma.
Processa Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Processa Pharma.
Processa Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is...
